Fasting or mediterranean diet? new study pits them Head-to-Head for weight loss
NCT ID NCT07250659
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study compared two popular diets for weight loss in 120 obese adults. One group followed intermittent fasting (eating only between 1 PM and 9 PM), while the other followed a traditional Mediterranean diet. Both diets cut about 500 calories per day. The goal was to see which approach led to more weight loss over 4 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Intermittent fasting (16:8 time-restricted eating) and Mediterranean diet
- What this could lead to
- If successful, this could show that intermittent fasting is as effective as the Mediterranean diet for short-term weight loss, offering another simple option for obesity management.
- What could go wrong
- This was a small, short-term (4-week) study with very healthy participants (no chronic diseases, no medications). Results may not apply to the general obese population or show long-term effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
European University of Lefke
Lefka, 99770, Cyprus
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Can popular Weight-Loss drugs alter breastmilk supply?
- A daily pill for obesity? zenagamtide faces its biggest test yet.